BEATW Market Analysis
News & Sentiment
1 article · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -164.2%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Heartbeam Inc. Warrant
Company profileHeartbeam Inc. Warrant (BEATW) represents a strategic investment aligned with Heartbeam Inc., a pioneering healthcare technology firm focused on transforming cardiac diagnostics through the integration of artificial intelligence and digital solutions. The company's cutting-edge platform enhances diagnostic precision for myocardial infarctions, facilitating timely interventions that significantly improve patient care outcomes. As the demand for innovative remote monitoring and telehealth services continues to escalate, Heartbeam is well-positioned to capture substantial market growth, making…
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NONE
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer